Ovid Therapeutics

General Information
Business:

We are a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. We believe these disorders represent an attractive area for drug development as the understanding of the underlying biology has grown meaningfully over the last few years; yet has remained underappreciated by the industry. Our experienced team began with a vision to integrate the biology and symptomology of rare neurological conditions to employ innovative research and clinical strategies for the development of our drug candidates.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 31
Founded: 2014
Contact Information
Address 1460 Broadway, Suite 15044, New York, New York 10036, US
Phone Number (646) 661-7661.
Web Address http://www.ovidrx.com
View Prospectus: Ovid Therapeutics
Financial Information
Market Cap $393.6mil
Revenues $0 mil (last 12 months)
Net Income $-22.4 mil (last 12 months)
IPO Profile
Symbol OVID
Exchange NASDAQ
Shares (millions): 5.0
Price range $15.00 - $15.00
Est. $ Volume $75.0 mil
Manager / Joint Managers Citigroup/ Cowen and Company
CO-Managers William Blair/ JMP Securities
Expected To Trade: 5/5/2017
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change